The use of panel testing in familial breast and ovarian cancer.
Clin Med (Lond)
; 17(6): 568-572, 2017 Dec.
Article
en En
| MEDLINE
| ID: mdl-29196360
ABSTRACT
Advances in sequencing technology have led to the introduction of panel testing in hereditary breast and ovarian cancer. While direct-to-consumer testing services have become widely available, the clinical validity of many of the genes on panel tests remains contentious and risk management guidelines are often lacking. This article gives an overview of advantages with panel testing as well as important challenges, including clinical translation of test results.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Pruebas Genéticas
/
Síndrome de Cáncer de Mama y Ovario Hereditario
Tipo de estudio:
Diagnostic_studies
/
Guideline
/
Prognostic_studies
Límite:
Female
/
Humans
Idioma:
En
Revista:
Clin Med (Lond)
Año:
2017
Tipo del documento:
Article
País de afiliación:
Reino Unido